Beta-tricalcium phosphate particles as a controlled release carrier of osteogenic proteins for bone tissue engineering

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 7, 2012, Pages 1680-1686

  Hu, Junli ^a   Hou, Yaping ^a   Park, Hyejin ^a   Lee, Min ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apatite; calcium phosphate; controlled release; protein; tissue engineering

Indexed keywords

APATITE COATING; BETA TRICALCIUM PHOSPHATE; BONE SUBSTITUTES; BONE TISSUE ENGINEERING; BURST RELEASE; CHEMICAL ETCHING; CITRIC ACID SOLUTION; CONTROLLED RELEASE; DIFFERENT SUBSTRATES; MODEL PROTEINS; OSTEOGENIC PROTEINS; PROTEIN CARRIER; PROTEIN RELEASE; RELEASE KINETICS; SIMULATE BODY FLUIDS; SURFACE ETCHING;

APATITE; BIOACTIVITY; BONE; CALCIUM PHOSPHATE; CITRIC ACID; ETCHING; LOADING; PHOSPHATE COATINGS; TISSUE ENGINEERING;

PROTEINS;

APATITE; CALCIUM PHOSPHATE; CITRIC ACID; NEL LIKE MOLECULE 1 PROTEIN; OSTEOGENIC PROTEIN 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BODY FLUID; BONE TISSUE; BONE TISSUE ENGINEERING; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN SECRETION; TISSUE ENGINEERING;

ANALYSIS OF VARIANCE; BONE AND BONES; CALCIUM PHOSPHATES; MICROSCOPY, ELECTRON, SCANNING; PROTEINS; TISSUE ENGINEERING;

EID: 84862805448     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34115     Document Type: Article

References (36)

1. Ozaki W, Buchman SR, Goldstein SA, Fyhrie DP,. A comparative analysis of the microarchitecture of cortical membranous and cortical endochondral onlay bone grafts in the craniofacial skeleton. Plast Reconstr Surg 1999; 104: 139-147.
2. Canady JW, Zeitler DP, Thompson SA, Nicholas CD,. Suitability of the iliac crest as a site for harvest of autogenous bone-grafts. Cleft Palate-Cran J 1993; 30: 579-581.
3. Strong EB, Moulthrop T,. Calvarial bone graft harvest: A new technique. Otolaryng Head Neck 2000; 123: 547-552.
4. Laurie SWS, Kaban LB, Mulliken JB, Murray JE,. Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg 1984; 73: 933-938.
5. Kurz LT, Garfin SR, Booth RE,. Harvesting autogenous iliac bone-grafts - A review of complications and techniques. Spine 1989; 14: 1324-1331.
6. Kline RM, Wolfe SA,. Complications associated with the harvesting of cranial bone-grafts. Plast Reconstr Surg 1995; 95: 5-13.
7. Wolfe SA,. Complications of harvesting cranial bone grafts. Plast Reconstr Surg 1996; 98: 567-567.
8. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN, Implants CB,. Bone-graft substitutes: Facts, fictions, and applications. J Bone Joint Surg Am A 2001; 83: 98-103.
9. Lye KW, Deatherage JK, Waite PD,. The use of demineralized bone matrix for grafting during Le Fort I and chin osteotomies: Techniques and complications. J Oral Maxil Surg 2008; 66: 1580-1585.
10. Takikawa S, Bauer TW, Kambic H, Togawa D,. Comparative evaluation of the osteoinductivity of two formulations of human demineralized bone matrix. J Biomed Mater Res A 2003; 65: 37-42.
11. Schwartz Z, Mellonig JT, Carnes DL, DelaFontaine J, Cochran DL, Dean DD, Boyan BD,. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 1996; 67: 918-926.
12. Creemers LB, Kempen DHR, Alblas J, Lu LC, Verbout AJ, Yaszemski MJ, Dhert WJA,. Growth factor interactions in bone regeneration. Tissue Eng Part B 2010; 16: 551-566.
13. Davies SD, Ochs MW,. Bone morphogenetic proteins in craniomaxillofacial surgery. Oral Maxillofac Surg Clin North Am 2010; 22: 17-31.
14. Kanakaris NK, Giannoudis PV,. Clinical applications of bone morphogenetic proteins: Current evidence. J Surg Orthop Adv 2008; 17: 133-46.
15. Sanfilippo JS, Lee J, Rihn J, Albert T, Hilibrand A,. BMP-2 causes increased postoperative radiculitis following TLIF. Spine J 2007; 7: 5S-6S.
16. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K,. Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008; 8: 1011-1018.
17. van den Bergh JPA, ten Bruggenkate CM, Groeneveld HHJ, Burger EH, Tuinzing DB,. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts - A clinical pilot study. J Clin Periodontol 2000; 27: 627-636.
18. Low KL, Tan SH, Zein SH, Roether JA, Mourino V, Boccaccini AR,. Calcium phosphate-based composites as injectable bone substitute materials. J Biomed Mater Res B Appl Biomater 2010; 94: 273-86.
19. Hak DJ,. The use of osteoconductive bone graft substitutes in orthopaedic trauma. J Am Acad Orthop Sur 2007; 15: 525-536.
20. Habraken WJEM, Wolke JGC, Jansen JA,. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 234-248.
21. Olton D, Li JH, Wilson ME, Rogers T, Close J, Huang L, Kumta PN, Sfeir C,. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 2007; 28: 1267-1279.
22. Bouler JM, Verron E, Khairoun I, Guicheux J,. Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discovery Today 2010; 15: 547-552.
23. Li W, Lee M, Whang J, Siu RK, Zhang X, Liu C, Wu BM, Wang JC, Ting K, Soo C,. Delivery of lyophilized Nell-1 in a rat spinal fusion model. Tissue Eng Part A 2010; 16: 2861-2870.
24. Boden SD, Kang J, Sandhu H, Heller JG,. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies. Spine 2002; 27: 2662-2673.
25. Lee M, Li W, Siu RK, Whang J, Zhang X, Soo C, Ting K, Wu BM,. Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials 2009; 30: 6094-101.
26. Chou YF, Dunn JCY, Wu BM,. In vitro response of MC3T3-E1 preosteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B 2005; 75: 81-90.
27. Zhang X, Zara J, Siu RK, Ting K, Soo C,. The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration. J Dent Res 2010; 89: 865-878.
28. Zhang XL, Kuroda S, Carpenter D, Nishimura I, Soo C, Moats R, Iida K, Wisner E, Hu FY, Miao S, Beanes S, Dang C, Vastardis H, Longaker M, Tanizawa K, Kanayama N, Saito N, Ting K,. Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 2002; 110: 861-870.
29. Zhang X, Ting K, Bessette CM, Culiat CT, Sung SJ, Lee H, Chen F, Shen J, Wang JJ, Kuroda S, Soo C,. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice. J Bone Miner Res 2011; 26: 777-791.
30. Truong T, Zhang XL, Pathmanathan D, Soo C, Ting K,. Craniosynostosis- associated gene Nell-1 is regulated by Runx2. J Bone Miner Res 2007; 22: 7-18.
31. Li W, Zara JN, Siu RK, Lee M, Aghaloo T, Zhang X, Wu BM, Gertzman AA, Ting K, Soo C,. Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model. Plast Reconstr Surg 2011; 127: 580-587.
32. Chou YF, Chiou WA, Xu YH, Dunn JCY, Wu BM,. The effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials 2004; 25: 5323-5331.
33. Chou YF, Huang WB, Dunn JCY, Miller TA, Wu BM,. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials 2005; 26: 285-295.
34. Kandori K, Shimizu T, Yasukawa A, Ishikawa T,. Adsorption of bovine serum-albumin onto synthetic calcium hydroxyapatite - influence of particle texture. Colloid Surf B 1995; 5: 81-87.
35. Koerten HK, van der Meulen J,. Degradation of calcium phosphate ceramics. J Biomed Mater Res 1999; 44: 78-86.
36. Layrolle P, Sohier J, Daculsi G, Sourice S, de Groot K,. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J Biomed Mater Res A 2010; 92: 1105-1114.